TRANSMEMBRANE NEOANTIGENIC PEPTIDES

The present disclosure provides transmembrane chimeric proteins derived from transposable element (TE)-exon fusion transcripts, as well as nucleic acids, antibodies, CARs, non-HLA restricted TCR and immune cells targeting such chimeric proteins that can be used in cancer therapy. La présente inventi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: BURBAGE, Marianne, STERN, Marc-Henri, SADACCA, Benjamin, LOPEZ LASTRA, Silvia, AMIGORENA, Sebastian, MERLOTTI IPPOLITO, Antonela, ARRIBAS DE SANDOVAL, Yagos, HOUY, Alexandre, WATERFALL, Joshua, GOUDOT, Christel
Format: Patent
Sprache:eng ; fre
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator BURBAGE, Marianne
STERN, Marc-Henri
SADACCA, Benjamin
LOPEZ LASTRA, Silvia
AMIGORENA, Sebastian
MERLOTTI IPPOLITO, Antonela
ARRIBAS DE SANDOVAL, Yagos
HOUY, Alexandre
WATERFALL, Joshua
GOUDOT, Christel
description The present disclosure provides transmembrane chimeric proteins derived from transposable element (TE)-exon fusion transcripts, as well as nucleic acids, antibodies, CARs, non-HLA restricted TCR and immune cells targeting such chimeric proteins that can be used in cancer therapy. La présente invention concerne des protéines chimériques transmembranaires dérivées de produits de transcription de fusion (TE)-exon à élément transposable, ainsi que des acides nucléiques, des anticorps, des CAR, des TCR restreints non HLA et des cellules immunitaires ciblant de telles protéines chimériques qui peuvent être utilisées dans une thérapie anticancéreuse.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2022189620A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2022189620A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2022189620A13</originalsourceid><addsrcrecordid>eNrjZFAOCXL0C_Z19XUC0q4Kfq7-jn4hnu6ufp7OCgGuASGeLq7BPAysaYk5xam8UJqbQdnNNcTZQze1ID8-tbggMTk1L7UkPtzfyMDIyNDC0szIwNHQmDhVAP5xI9s</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>TRANSMEMBRANE NEOANTIGENIC PEPTIDES</title><source>esp@cenet</source><creator>BURBAGE, Marianne ; STERN, Marc-Henri ; SADACCA, Benjamin ; LOPEZ LASTRA, Silvia ; AMIGORENA, Sebastian ; MERLOTTI IPPOLITO, Antonela ; ARRIBAS DE SANDOVAL, Yagos ; HOUY, Alexandre ; WATERFALL, Joshua ; GOUDOT, Christel</creator><creatorcontrib>BURBAGE, Marianne ; STERN, Marc-Henri ; SADACCA, Benjamin ; LOPEZ LASTRA, Silvia ; AMIGORENA, Sebastian ; MERLOTTI IPPOLITO, Antonela ; ARRIBAS DE SANDOVAL, Yagos ; HOUY, Alexandre ; WATERFALL, Joshua ; GOUDOT, Christel</creatorcontrib><description>The present disclosure provides transmembrane chimeric proteins derived from transposable element (TE)-exon fusion transcripts, as well as nucleic acids, antibodies, CARs, non-HLA restricted TCR and immune cells targeting such chimeric proteins that can be used in cancer therapy. La présente invention concerne des protéines chimériques transmembranaires dérivées de produits de transcription de fusion (TE)-exon à élément transposable, ainsi que des acides nucléiques, des anticorps, des CAR, des TCR restreints non HLA et des cellules immunitaires ciblant de telles protéines chimériques qui peuvent être utilisées dans une thérapie anticancéreuse.</description><language>eng ; fre</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20220915&amp;DB=EPODOC&amp;CC=WO&amp;NR=2022189620A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20220915&amp;DB=EPODOC&amp;CC=WO&amp;NR=2022189620A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>BURBAGE, Marianne</creatorcontrib><creatorcontrib>STERN, Marc-Henri</creatorcontrib><creatorcontrib>SADACCA, Benjamin</creatorcontrib><creatorcontrib>LOPEZ LASTRA, Silvia</creatorcontrib><creatorcontrib>AMIGORENA, Sebastian</creatorcontrib><creatorcontrib>MERLOTTI IPPOLITO, Antonela</creatorcontrib><creatorcontrib>ARRIBAS DE SANDOVAL, Yagos</creatorcontrib><creatorcontrib>HOUY, Alexandre</creatorcontrib><creatorcontrib>WATERFALL, Joshua</creatorcontrib><creatorcontrib>GOUDOT, Christel</creatorcontrib><title>TRANSMEMBRANE NEOANTIGENIC PEPTIDES</title><description>The present disclosure provides transmembrane chimeric proteins derived from transposable element (TE)-exon fusion transcripts, as well as nucleic acids, antibodies, CARs, non-HLA restricted TCR and immune cells targeting such chimeric proteins that can be used in cancer therapy. La présente invention concerne des protéines chimériques transmembranaires dérivées de produits de transcription de fusion (TE)-exon à élément transposable, ainsi que des acides nucléiques, des anticorps, des CAR, des TCR restreints non HLA et des cellules immunitaires ciblant de telles protéines chimériques qui peuvent être utilisées dans une thérapie anticancéreuse.</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZFAOCXL0C_Z19XUC0q4Kfq7-jn4hnu6ufp7OCgGuASGeLq7BPAysaYk5xam8UJqbQdnNNcTZQze1ID8-tbggMTk1L7UkPtzfyMDIyNDC0szIwNHQmDhVAP5xI9s</recordid><startdate>20220915</startdate><enddate>20220915</enddate><creator>BURBAGE, Marianne</creator><creator>STERN, Marc-Henri</creator><creator>SADACCA, Benjamin</creator><creator>LOPEZ LASTRA, Silvia</creator><creator>AMIGORENA, Sebastian</creator><creator>MERLOTTI IPPOLITO, Antonela</creator><creator>ARRIBAS DE SANDOVAL, Yagos</creator><creator>HOUY, Alexandre</creator><creator>WATERFALL, Joshua</creator><creator>GOUDOT, Christel</creator><scope>EVB</scope></search><sort><creationdate>20220915</creationdate><title>TRANSMEMBRANE NEOANTIGENIC PEPTIDES</title><author>BURBAGE, Marianne ; STERN, Marc-Henri ; SADACCA, Benjamin ; LOPEZ LASTRA, Silvia ; AMIGORENA, Sebastian ; MERLOTTI IPPOLITO, Antonela ; ARRIBAS DE SANDOVAL, Yagos ; HOUY, Alexandre ; WATERFALL, Joshua ; GOUDOT, Christel</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2022189620A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2022</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>BURBAGE, Marianne</creatorcontrib><creatorcontrib>STERN, Marc-Henri</creatorcontrib><creatorcontrib>SADACCA, Benjamin</creatorcontrib><creatorcontrib>LOPEZ LASTRA, Silvia</creatorcontrib><creatorcontrib>AMIGORENA, Sebastian</creatorcontrib><creatorcontrib>MERLOTTI IPPOLITO, Antonela</creatorcontrib><creatorcontrib>ARRIBAS DE SANDOVAL, Yagos</creatorcontrib><creatorcontrib>HOUY, Alexandre</creatorcontrib><creatorcontrib>WATERFALL, Joshua</creatorcontrib><creatorcontrib>GOUDOT, Christel</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>BURBAGE, Marianne</au><au>STERN, Marc-Henri</au><au>SADACCA, Benjamin</au><au>LOPEZ LASTRA, Silvia</au><au>AMIGORENA, Sebastian</au><au>MERLOTTI IPPOLITO, Antonela</au><au>ARRIBAS DE SANDOVAL, Yagos</au><au>HOUY, Alexandre</au><au>WATERFALL, Joshua</au><au>GOUDOT, Christel</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>TRANSMEMBRANE NEOANTIGENIC PEPTIDES</title><date>2022-09-15</date><risdate>2022</risdate><abstract>The present disclosure provides transmembrane chimeric proteins derived from transposable element (TE)-exon fusion transcripts, as well as nucleic acids, antibodies, CARs, non-HLA restricted TCR and immune cells targeting such chimeric proteins that can be used in cancer therapy. La présente invention concerne des protéines chimériques transmembranaires dérivées de produits de transcription de fusion (TE)-exon à élément transposable, ainsi que des acides nucléiques, des anticorps, des CAR, des TCR restreints non HLA et des cellules immunitaires ciblant de telles protéines chimériques qui peuvent être utilisées dans une thérapie anticancéreuse.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre
recordid cdi_epo_espacenet_WO2022189620A1
source esp@cenet
subjects CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title TRANSMEMBRANE NEOANTIGENIC PEPTIDES
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T10%3A54%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=BURBAGE,%20Marianne&rft.date=2022-09-15&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2022189620A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true